Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Pin1 is beneficial in Alzheimer's disease, detrimental to some forms of dementia

23.04.2008
Unexpected findings suggest need for alternate therapeutic approaches, different animal models for future research

The most common form of dementia, Alzheimer’s disease, and a relatively rare hereditary form of dementia, frontotemporal dementia with parkinsonism-17, share a common pathology: Both are the result of an overaccumulation of tau proteins, which form tangled lesions in the brain’s neurons and eventually lead to the collapse of the brain cells responsible for memory.

And, although mutations in the gene encoding tau have not been found in individuals with Alzheimer’s disease, they have been identified in individual with frontotemporal dementia, and are often used as models for studying Alzheimer’s disease.

A new study finds that the Pin1 enzyme, previously shown to be of benefit in “detangling” tau in Alzheimer’s disease, actually has the contradictory effect in cases in which the tau has certain mutations. Consequently, while increasing Pin1 in neurons effectively suppresses the disease development in cases of Alzheimer’s, it actually accelerates disease progression in the case of frontotemporal dementia.

Led by researchers at Beth Israel Deaconess Medical Center (BIDMC) and reported in the April 22 advance on-line issue of The Journal of Clinical Investigation, these new findings offer novel ideas for the development of therapies for Alzheimer’s disease and other dementias, and also point to the importance of using appropriate animal models for studying distinct tau-related neurodegenerative disorders and screening for therapeutic drugs.

“We were completely surprised to discover these diametrically opposed outcomes,” explains senior author Kun Ping Lu, MD, PhD, a scientist in the Division of Hematology/Oncology at BIDMC and Professor of Medicine at Harvard Medical School. “It appears that while boosting Pin1 activity is beneficial in cases of Alzheimer’s disease, inhibition of Pin1 is helpful for dementias that carry the P301L tau mutation [as is the case with frontotemporal dementia].”

Pin1 (prolyl isomerase) was first discovered by Lu and Salk Institute investigator Tony Hunter in 1995. In 2003, Lu and colleagues demonstrated that Pin1 promotes the removal of phosphates from tau, thereby “detangling” the protein which, in cases of Alzheimer’s disease, had become knotted and overburdened with excess phosphate molecules. Three years later, in 2006, the Lu team discovered that Pin1 also inhibits the production of toxic amyloid Abeta peptides, the central component of senile plaques and the second neuropathological hallmark in brains of Alzheimer’s patients. They further confirmed that when Pin1 was missing, neurons in regions of the brain responsible for memory would collapse under the weight of the tau protein tangles and toxic amyloid peptides, ultimately leading to age-dependent neurodegeneration. Together with other findings that Pin1 activity is inhibited in Alzheimer’s brains by many conditions, such as stresses, these results indicate that loss of Pin1 activity is a major contributing factor in the development of Alzheimer’s disease.

In this latest study, Lu and his coauthors set out to learn if by boosting levels of the Pin1 enzyme, the onset of Alzheimer’s could be prevented.

As predicted, the investigators found in both human cell lines and in mice that when Pin1 was normally present, the tau proteins readily degraded; when the enzyme was removed, the tau proteins stabilized and failed to break down. Subsequent mouse experiments in which Pin1 was moderately overexpressed in brain cells 10 days after birth again found that the tau protein degraded much more quickly than it did in normal control mice.

But, when the scientists next went on to cross two separate mouse models – those that overexpressed the Pin1 enzyme and mouse models of Alzheimer’s disease – they made a surprising discovery: Not only did the exact same Pin1 overexpression not suppress tau stability, it actually exacerbated the tau pathology and neurodegeneration among mice overexpressing P301L tau mutant.

“Transgenic mice overexpressing human wild-type tau or tau mutants have been typically used as Alzheimer’s models,” explains Lu, adding that the P301L-tau-mutant- mice are widely preferred due to their robust tau pathology and neurodegeneration. However, since no tau mutations are found in cases of Alzheimer’s disease, it remains unclear as to how appropriate tau mutant mice actually are as an Alzheimer’s model.

“The significance of our findings are two-fold,” he notes. “First, we have established a proof of concept that boosting Pin1 activity may offer a new idea for preventing or even treating the tau pathology and neurodegeneration in Alzheimer’s disease.

“And, second, given that no tau mutation is found in Alzheimer’s patients, this research suggests that it would be prudent to not use P301L tau as an Alzheimer's disease model, especially when screening and testing drugs, as it may produce diametrically opposite effects. Therefore, it is critical to use appropriate animal models for studying distinct tau-related neurodegenerative disorders and to develop disease-specific therapies for these devastating diseases.”

Bonnie Prescott | EurekAlert!
Further information:
http://www.bidmc.harvard.edu

More articles from Studies and Analyses:

nachricht Rutgers-led innovation could spur faster, cheaper, nano-based manufacturing
14.02.2018 | Rutgers University

nachricht New study from the University of Halle: How climate change alters plant growth
12.01.2018 | Martin-Luther-Universität Halle-Wittenberg

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Attoseconds break into atomic interior

A newly developed laser technology has enabled physicists in the Laboratory for Attosecond Physics (jointly run by LMU Munich and the Max Planck Institute of Quantum Optics) to generate attosecond bursts of high-energy photons of unprecedented intensity. This has made it possible to observe the interaction of multiple photons in a single such pulse with electrons in the inner orbital shell of an atom.

In order to observe the ultrafast electron motion in the inner shells of atoms with short light pulses, the pulses must not only be ultrashort, but very...

Im Focus: Good vibrations feel the force

A group of researchers led by Andrea Cavalleri at the Max Planck Institute for Structure and Dynamics of Matter (MPSD) in Hamburg has demonstrated a new method enabling precise measurements of the interatomic forces that hold crystalline solids together. The paper Probing the Interatomic Potential of Solids by Strong-Field Nonlinear Phononics, published online in Nature, explains how a terahertz-frequency laser pulse can drive very large deformations of the crystal.

By measuring the highly unusual atomic trajectories under extreme electromagnetic transients, the MPSD group could reconstruct how rigid the atomic bonds are...

Im Focus: Developing reliable quantum computers

International research team makes important step on the path to solving certification problems

Quantum computers may one day solve algorithmic problems which even the biggest supercomputers today can’t manage. But how do you test a quantum computer to...

Im Focus: In best circles: First integrated circuit from self-assembled polymer

For the first time, a team of researchers at the Max-Planck Institute (MPI) for Polymer Research in Mainz, Germany, has succeeded in making an integrated circuit (IC) from just a monolayer of a semiconducting polymer via a bottom-up, self-assembly approach.

In the self-assembly process, the semiconducting polymer arranges itself into an ordered monolayer in a transistor. The transistors are binary switches used...

Im Focus: Demonstration of a single molecule piezoelectric effect

Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale

Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

2nd International Conference on High Temperature Shape Memory Alloys (HTSMAs)

15.02.2018 | Event News

Aachen DC Grid Summit 2018

13.02.2018 | Event News

How Global Climate Policy Can Learn from the Energy Transition

12.02.2018 | Event News

 
Latest News

Basque researchers turn light upside down

23.02.2018 | Physics and Astronomy

Finnish research group discovers a new immune system regulator

23.02.2018 | Health and Medicine

Attoseconds break into atomic interior

23.02.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>